Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Leveraging the AhR pathway and immune checkpoint interaction to innovate the management of IFNγ mediated diseases: focus on vitiligo and alopecia areata

Outputs and Outcomes

Code

DOCT/013573

Duration

12 June 2025 → 20 September 2026 (Ongoing)

Doctoral researcher

Elise Van Caelenberg

Research disciplines

No data available

Project description

No data available